Literature DB >> 22559231

Activation-induced deaminase contributes to the antibody-independent role of B cells in the development of autoimmunity.

Chuancang Jiang1, Ming-Lang Zhao, Katherine M Waters, Marilyn Diaz.   

Abstract

B cells contribute to autoimmunity both as secretors of pathogenic antibodies and through the activation of autoreactive T cells. B cells and antibodies acquire higher affinity to self-antigen through a process known as immunoglobulin hypermutation or SHM. The contribution of SHM to pathogenic antibody development in lupus has been established in various autoimmune mouse models and by examining antibodies from patients. However, its role in the antibody-independent contribution of B cells to autoimmunity has not been examined. Herein, we generate lupus-prone MRL/lpr mice with a limited IgM-only B cell repertoire, no secreted antibodies and no SHM. This enabled us to isolate the role of somatic hypermutation in B cell-mediated autoimmunity. We found that SHM-deficiency correlated with a reduction in autoreactive B cells, a decrease in T cell activation and a decrease in kidney lymphocytic infiltration. These data establish AID as an important contributor to the antibody-independent role of B cells in autoimmunity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22559231      PMCID: PMC3496248          DOI: 10.3109/08916934.2012.682668

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  38 in total

1.  VARIATIONS IN AFFINITIES OF ANTIBODIES DURING THE IMMUNE RESPONSE.

Authors:  H N EISEN; G W SISKIND
Journal:  Biochemistry       Date:  1964-07       Impact factor: 3.162

2.  The evolution of human anti-double-stranded DNA autoantibodies.

Authors:  Ute Wellmann; Miriam Letz; Martin Herrmann; Sieglinde Angermüller; Joachim R Kalden; Thomas H Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-20       Impact factor: 11.205

3.  A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr/lpr mice.

Authors:  O Chan; M J Shlomchik
Journal:  J Immunol       Date:  1998-01-01       Impact factor: 5.422

4.  Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice.

Authors:  W L Hazenbos; J E Gessner; F M Hofhuis; H Kuipers; D Meyer; I A Heijnen; R E Schmidt; M Sandor; P J Capel; M Daëron; J G van de Winkel; J S Verbeek
Journal:  Immunity       Date:  1996-08       Impact factor: 31.745

5.  Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice.

Authors:  Djemel Aït-Azzouzene; Dwight H Kono; Rosana Gonzalez-Quintial; Louise J McHeyzer-Williams; Min Lim; Dilki Wickramarachchi; Tobias Gerdes; Amanda L Gavin; Patrick Skog; Michael G McHeyzer-Williams; David Nemazee; Argyrios N Theofilopoulos
Journal:  J Immunol       Date:  2010-06-16       Impact factor: 5.422

6.  Activation-induced deaminase heterozygous MRL/lpr mice are delayed in the production of high-affinity pathogenic antibodies and in the development of lupus nephritis.

Authors:  Chuancang Jiang; Ming Lang Zhao; Marilyn Diaz
Journal:  Immunology       Date:  2008-06-20       Impact factor: 7.397

Review 7.  Why can't we find a new treatment for SLE?

Authors:  Robert Eisenberg
Journal:  J Autoimmun       Date:  2009-03-28       Impact factor: 7.094

8.  The lupus susceptibility locus Sle1 breaches peripheral B cell tolerance at the antibody-forming cell and germinal center checkpoints.

Authors:  Raja Vuyyuru; Chandra Mohan; Tim Manser; Ziaur S M Rahman
Journal:  J Immunol       Date:  2009-10-14       Impact factor: 5.422

9.  Abrogation of lupus nephritis in activation-induced deaminase-deficient MRL/lpr mice.

Authors:  Chuancang Jiang; Julie Foley; Natasha Clayton; Grace Kissling; Micheal Jokinen; Ronald Herbert; Marilyn Diaz
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

10.  A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus.

Authors:  O T Chan; L G Hannum; A M Haberman; M P Madaio; M J Shlomchik
Journal:  J Exp Med       Date:  1999-05-17       Impact factor: 14.307

View more
  6 in total

1.  Activation-induced cytidine deaminase deficiency accelerates autoimmune diabetes in NOD mice.

Authors:  Qiyuan Tan; Ningwen Tai; Yangyang Li; James Pearson; Sean Pennetti; Zhiguang Zhou; F Susan Wong; Li Wen
Journal:  JCI Insight       Date:  2018-01-11

Review 2.  Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Authors:  Anne Durandy; Tineke Cantaert; Sven Kracker; Eric Meffre
Journal:  Autoimmunity       Date:  2013-01-10       Impact factor: 2.815

Review 3.  Autoimmunity in 2012.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2013-10       Impact factor: 8.667

Review 4.  Novel Implications in Molecular Diagnosis of Lynch Syndrome.

Authors:  Raffaella Liccardo; Marina De Rosa; Paola Izzo; Francesca Duraturo
Journal:  Gastroenterol Res Pract       Date:  2017-01-29       Impact factor: 2.260

5.  Aberrant expression of interleukin-10 and activation-induced cytidine deaminase in B cells from patients with Behçet's disease.

Authors:  Jeong-Yun Yoon; Yeojin Lee; Seong-Lan Yu; Hee-Kyung Yoon; Ha-Yan Park; Chung-Il Joung; Seok-Rae Park; Mihye Kwon; Jaeku Kang
Journal:  Biomed Rep       Date:  2017-10-04

6.  Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.

Authors:  Georgina Galicia; Bryant Boulianne; Natalia Pikor; Alberto Martin; Jennifer L Gommerman
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.